Spyre Therapeutics Inc (SYRE)

Income Before Tax

-$178.92M

TTM · Period ending: · USD

SYRE logo

SYRE Income Before Tax

Latest reported-$178.92M
SYRE TTM Pre-Tax Income (-$10.35M → -$178.92M)
High-resolution chart · PNG

SYRE income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Spyre Therapeutics Inc Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
-178,918,000
-179,435,000
-155,218,000
-148,983,000
-206,810,000
-208,930,000
-207,967,000
-214,852,000
-185,946,000
-364,183,000
-338,816,000
-294,420,000
-272,759,000
-77,999,000
-83,977,000
-85,616,000
-87,454,000
-71,878,000
-65,660,000
-67,951,000
-65,703,000
-80,383,000
-80,893,000
-79,674,000
-83,214,000
-79,815,000
-78,254,000
-71,657,000
-62,001,000
-53,396,000
-44,348,000
-35,933,000
-31,890,000
-29,108,000
-27,236,000
-26,236,000
-24,600,000
-23,398,000
-21,698,000
-20,202,000
-17,377,000
-13,374,000
-11,295,000
-10,489,000
-10,326,000
-11,295,000
-10,347,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.